BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 26420286)

  • 1. NPHS2 mutations account for only 15% of nephrotic syndrome cases.
    Guaragna MS; Lutaif AC; Piveta CS; Souza ML; de Souza SR; Henriques TB; Maciel-Guerra AT; Belangero VM; Guerra-Junior G; De Mello MP
    BMC Med Genet; 2015 Sep; 16():88. PubMed ID: 26420286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).
    Hinkes BG; Mucha B; Vlangos CN; Gbadegesin R; Liu J; Hasselbacher K; Hangan D; Ozaltin F; Zenker M; Hildebrandt F;
    Pediatrics; 2007 Apr; 119(4):e907-19. PubMed ID: 17371932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
    Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
    Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome.
    Sako M; Nakanishi K; Obana M; Yata N; Hoshii S; Takahashi S; Wada N; Takahashi Y; Kaku Y; Satomura K; Ikeda M; Honda M; Iijima K; Yoshikawa N
    Kidney Int; 2005 Apr; 67(4):1248-55. PubMed ID: 15780077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.
    Bińczak-Kuleta A; Rubik J; Litwin M; Ryder M; Lewandowska K; Taryma-Leśniak O; Clark JS; Grenda R; Ciechanowicz A
    Bosn J Basic Med Sci; 2014 May; 14(2):89-93. PubMed ID: 24856380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome.
    Gbadegesin R; Hinkes B; Vlangos C; Mucha B; Liu J; Hopcian J; Hildebrandt F
    Pediatr Nephrol; 2007 Apr; 22(4):509-13. PubMed ID: 17216259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations in steroid-resistant nephrotic syndrome diagnosed in Tunisian children.
    Mbarek IB; Abroug S; Omezzine A; Pawtowski A; Gubler MC; Bouslama A; Harbi A; Antignac C
    Pediatr Nephrol; 2011 Feb; 26(2):241-9. PubMed ID: 21125408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A spectrum of novel NPHS1 and NPHS2 gene mutations in pediatric nephrotic syndrome patients from Pakistan.
    Abid A; Khaliq S; Shahid S; Lanewala A; Mubarak M; Hashmi S; Kazi J; Masood T; Hafeez F; Naqvi SA; Rizvi SA; Mehdi SQ
    Gene; 2012 Jul; 502(2):133-7. PubMed ID: 22565185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
    Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPHS2 mutations in children with steroid-resistant nephrotic syndrome.
    Otukesh H; Ghazanfari B; Fereshtehnejad SM; Bakhshayesh M; Hashemi M; Hoseini R; Chalian M; Salami A; Mehdipor L; Rahiminia A
    Iran J Kidney Dis; 2009 Apr; 3(2):99-102. PubMed ID: 19395786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in NPHS2 (podocin) in Mexican children with nephrotic syndrome who respond to standard steroid treatment.
    Carrasco-Miranda JS; Garcia-Alvarez R; Sotelo-Mundo RR; Valenzuela O; Islas-Osuna MA; Sotelo-Cruz N
    Genet Mol Res; 2013 Jun; 12(2):2102-7. PubMed ID: 23913389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
    Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
    Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening in children with challenging nephrotic syndrome.
    Saeed B
    Saudi J Kidney Dis Transpl; 2020; 31(6):1189-1197. PubMed ID: 33565430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of novel genetic variation in NPHS2 gene associated with idiopathic nephrotic syndrome in South Indian children.
    Dhandapani MC; Venkatesan V; Rengaswamy NB; Gowrishankar K; Ekambaram S; Sengutavan P; Perumal V
    Clin Exp Nephrol; 2017 Feb; 21(1):127-133. PubMed ID: 26820844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome.
    Wang F; Zhang Y; Mao J; Yu Z; Yi Z; Yu L; Sun J; Wei X; Ding F; Zhang H; Xiao H; Yao Y; Tan W; Lovric S; Ding J; Hildebrandt F
    Pediatr Nephrol; 2017 Jul; 32(7):1181-1192. PubMed ID: 28204945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of p.Ser1105Ser (in
    Thi Kim Lien N; Van Dem P; Thu Huong N; Minh Dien T; Thi Thu Thuy T; Van Tung N; Huy Hoang N; Thi Quynh Huong N
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 31013750
    [No Abstract]   [Full Text] [Related]  

  • 17. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.
    Weber S; Gribouval O; Esquivel EL; Morinière V; Tête MJ; Legendre C; Niaudet P; Antignac C
    Kidney Int; 2004 Aug; 66(2):571-9. PubMed ID: 15253708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NPHS2 Mutation analysis study in children with steroid-resistant nephrotic syndrome].
    Azocar M; Vega Á; Farfán M; Cano F
    Rev Chil Pediatr; 2016; 87(1):31-6. PubMed ID: 26455708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.
    Santín S; Bullich G; Tazón-Vega B; García-Maset R; Giménez I; Silva I; Ruíz P; Ballarín J; Torra R; Ars E
    Clin J Am Soc Nephrol; 2011 May; 6(5):1139-48. PubMed ID: 21415313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.
    Ruf RG; Lichtenberger A; Karle SM; Haas JP; Anacleto FE; Schultheiss M; Zalewski I; Imm A; Ruf EM; Mucha B; Bagga A; Neuhaus T; Fuchshuber A; Bakkaloglu A; Hildebrandt F;
    J Am Soc Nephrol; 2004 Mar; 15(3):722-32. PubMed ID: 14978175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.